stockrowTakeda Pharmaceutical Co. (TAK) vs Viatris Inc. (VTRS)
- Takeda Pharmaceutical Co. TAK 21.25 +0.90%
- Viatris Inc. VTRS 18.89 −1.72%
Takeda Pharmaceutical Co. and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $67.7B against $21.8B — 3.1× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Takeda Pharmaceutical Co. trades at 32.0×. Viatris Inc. grew revenue faster over the last twelve months: 4.27% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs −4.13%) and the higher return on invested capital (0.00% vs −0.02%). Both pay a dividend; Viatris Inc. yields more (2.54% vs 1.45%). Across the 21 metrics below, Takeda Pharmaceutical Co. leads on 12 and Viatris Inc. on 9.
Valuation
Profitability
| Metric | TAK | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 35.31% | 53.51% |
| Operating margin | 11.61% | (0.03%) | 0.00% |
| Net margin | 7.12% | (4.13%) | (2.45%) |
| Free cash flow margin | 0.00% | 16.27% | 0.00% |
| Return on equity | 0.00% | (4.21%) | (0.80%) |
| Return on assets | 0.00% | (1.67%) | (1.67%) |
| Return on invested capital | 0.00% | (0.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack